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An 80-year-old farmer with arthritis, anemia, chronic kidney disease, and a history of shingles presented with a 3-month history of a painful, nonhealing, ulcerative pinna lesion refractory to antibiotics and local wound care (figure 1). He reported a subsequent development of similar ulcerative lesions involving the oral tongue and floor of his mouth.
Biopsy of the pinna and oral cavity revealed diffuse, mixed inflammatory infiltrate and numerous epithelioid histiocytes containing small, circular yeast cells compatible with Histoplasma capsulatum (figure 2). Special stains for fungal organisms, including Gomori methenamine silver (GMS) and periodic acid-Schiff (PAS) were strongly positive (figure 3).
The patient had no clinical or laboratory findings to suggest systemic fungal infection, so oral itraconazole was initiated for treatment of primary cutaneous histoplasmosis with dissemination to the oral cavity. Despite a promising initial clinical response, the medication was withdrawn several weeks into therapy because of the patient's worsening renal function. Hemodialysis was initiated; however, the patient's health progressively deteriorated, and he passed away a few months later from renal-, heart-, and liver-associated complications.
H capsulatum is a soil saprophyte endemic to the Ohio and Mississippi River valleys, often found in chicken habitats or caves inhabited by bats and birds. Infection by inhalation of aerosolized H capsulatum microconidia primarily affects the lungs of immunosuppressed individuals, although a variety of clinical presentations exist. 1 Histoplasmosis of the skin, a less common presentation, occurs either secondarily via systemic infection that disseminates to the skin, or primarily via direct inoculation of H capsulatum during injury to the skin.
1,2 The latter disease process, termed primary cutaneous histoplasmosis (PCH), rarely presents in the head and neck and is poorly described in the otolaryngologic literature. 3 Patients with PCH present with nonspecific skin lesions including papules, plaques, ulcers, purpura, abscesses, impetigo, or dermatitis. 4 Diagnosis hinges on evidence of fungus in the wound and absence of systemic disease. Tissue biopsy of the cutaneous lesion should be performed promptly. Microscopy may reveal fungal elements and granuloma formation, but histopathology showing any distinctive 2-to 4-µm, oval, narrow-based budding yeasts secures the diagnosis ( figure 2) . 
. Hematoxylin and eosin (H & E)-stained sections demonstrate numerous vacuolated areas (arrows) surrounded by a diffuse, mixed inflammatory infiltrate (A; original magnification ×20) and numerous epithelioid histiocytes with small, circular yeast cells (arrows), characteristic of H capsulatum (B; original magnification ×40).

Figure 3. GMS (A) and PAS (B) stains highlight numerous aggregates and randomly distributed organisms of H capsulatum (original magnification ×40).
GMS and PAS stains (figure 3) help identify H capsulatum in macrophages and within the tissue. Cultures showing small, oval, budding yeast can be used to confirm the diagnosis, but their results often take several weeks. Antigen detection is a sensitive method used for ruling out disseminated disease. [1] [2] [3] Treatment of PCH depends on the extent and severity of the disease. Topical amphotericin B and nystatin can be used for limited disease, while systemic amphotericin B and itraconazole often are reserved for more widespread lesions. 5 Incision and drainage may be necessary for lesions refractory to medical therapy. with Epstein-Barr virus in a child with congenital immunodeficiency. 6 There are several treatment options for LMS. In many reported cases, thyroid lobectomy or total thyroidectomy with or without neck dissection has been the first choice for treatment. Although surgery is the most commonly accepted treatment for the disease, no treatment has shown effectiveness. However, it is difficult to make an exact diagnosis of LMS before surgery and to distinguish it from anaplastic thyroid cancer, especially the spindle-cell variant of anaplastic thyroid cancer. 1, 2 
